SPG302
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for SPG302, covering 2025-06-29 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of SPG302 in Adults With Schizophrenia [Phase 2]